ENTERA BIO LTD. (ENTX)
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
WEARABLE DEVICES LTD. (WLDS)
Wearable Devices to Unveil GenAI-Powered Intent-Based Interface Platform and Next-Gen Mudra Pro Flagship at AWE 2026
QUANTUM CORP /DE/ (QMCO)
Quantum Corporation Files Form 12b-25 Notification of Late Filing
NEUROCRINE BIOSCIENCES INC (NBIX)
Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026
BLOCKCHAIN DIGITAL INFRASTRUCTURE, INC. (AIB)
BlockchAIn Announces Corporate Name Change to AIB Data Centers Inc.
Cadrenal Therapeutics Inc (CVKD)
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
Alto Ingredients Inc (ALTO)
Alto Ingredients, Inc. Completes Transaction to Monetize All 2025 45Z Clean Fuel Production Tax Credits
CAPSTONE GREEN ENERGY HOLDINGS INC. (CGEH)
Capstone Energy+ to Host Fourth Quarter and Full Fiscal Year 2026 Earnings Conference Call on June 25, 2026
AERIES TECHNOLOGY, INC. (AERT)
Aeries Technology Secures Strategic GCC Advisory Mandate with Leading Global Tax and Financial Advisory Platform
CADRENAL THERAPEUTICS, INC. (CVKD)
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026